Sustained reduction in bronchial hyperresponsiveness within three days of inhaled fluticasone propionate in mild asthma:time course after onset and cessation of treatment
Sovijärvi, A.R.A.; Haahtela, T.; Ekroos, H.J.; Lindqvist, A.; Saarinen, A.; Poussa, T.; Laitinen, L.A.
Duodecim; Laaketieteellinen Aikakauskirja 120(13): 1591-1593
2004
ISSN/ISBN: 0012-7183 PMID: 15326966 Document Number: 584055
Document emailed within 1 workday
Related Documents
Sheffer, A.L.; LaForce, C.; Chervinsky, P.; Pearlman, D.; Schaberg, A. 1996: Fluticasone propionate aerosol: efficacy in patients with mild to moderate asthma. Fluticasone Propionate Asthma Study Group Journal of Family Practice 42(4): 369-375Wongtim, S.; Mogmued, S.; Chareonlap, P.; Limthongkul, S. 1995: Effect of inhaled corticosteroids on bronchial hyperresponsiveness in patients with mild asthma Asian Pacific Journal of Allergy and Immunology 13(2): 81-85
Lange, P.; Vestbo, J. 1996: Fluticasone propionate--a new inhalation steroid for the treatment of bronchial asthma Ugeskrift for Laeger 158(4): 439-444
Kupryś-Lipińska, I.; Tworek, D.; Vanderbist, F.; Bocheńska-Marciniak, M.łg.; Kuna, P. 2013: Efficacy and safety of a 12-week therapy with a new formulation of fluticasone propionate at doses of 125 and 250 μg administered through a new generation cyclohaler twice daily, in comparison to fluticasone propionate 500 μg dry powder inhaler twice daily in patients with moderate asthma Pneumonologia i Alergologia Polska 81(6): 527-536
Purello-D'Ambrosio, F.; Gangemi, S.; Merendino, R.A.; Arena, A.; Guarneri, F.; Ricciardi, L. 1999: Effect of fluticasone propionate on interleukin-12 and interferon-gamma production in patients affected by allergic bronchial asthma Journal of Investigational Allergology and Clinical Immunology 9(4): 262-267
Chung, K.F. 1995: Eformoterol and bronchial hyperresponsiveness in mild asthma British Journal of Clinical Practice. Suppl 81: 14-15
Solidoro, P.; Donati, G.; Magnoni, M.S. 2003: Fluticasone propionate in the treatment of airway inflammations (asthma and rhinitis) Minerva Pediatrica 55(4): 345-355
Krishnaswami, S.; Hochhaus, G.; Möllmann, H.; Barth, J.; Derendorf, H. 2005: Interpretation of absorption rate data for inhaled fluticasone propionate obtained in compartmental pharmacokinetic modeling International Journal of Clinical Pharmacology and Therapeutics 43(3): 117-122
Ikeda, A.; Nishimura, K.; Koyama, H.; Tsukino, M.; Izumi, T. 1995: Effect of one year of treatment with inhaled beclomethasone dipropionate on airway hyperresponsiveness in stable chronic asthma Nihon Kyobu Shikkan Gakkai Zasshi 33(5): 505-509
Stoloff, S.; Samuels, S.; Kerney, D.; Brown, C.P. 2006: Management of chronic obstructive pulmonary disease associated with chronic bronchitis with inhaled fluticasone propionate/salmeterol (ADVAIR DISKUS) 250/50: results of a patient experience trial Medgenmed: Medscape General Medicine 8(1): 86
Von Berg, A.; Gappa, M.; Steinkamp, G. 2002: Fluticasone for the treatment of symptomatic bronchial asthma in children treated with sodium cromogylate--a prospective, randomised trial European Journal of Medical Research 7(6): 257-264
Neijens, H.J.; de Jongste, J.J.; Degenhart, H.J.; Kerrebijn, K.F. 1984: Dysregulation of mediator release in relation to bronchial asthma and bronchial hyperresponsiveness Agents and Actions. Supplements 14: 59-68
Miyatake, H.; Suzuki, K.; Taki, F.; Takagi, K.; Satake, T. 1991: Effect of erythromycin on bronchial hyperresponsiveness in patients with bronchial asthma Arzneimittel-Forschung 41(5): 552-556
Doull, I. 1998: Making the diagnosis of asthma. Relation between asthma and bronchial hyperresponsiveness is not clear cut Bmj 316(7125): 150
Park, J.W.; Hong, Y.K.; Kim, C.W.; Kim, D.K.; Choe, K.O.; Hong, C.S. 1997: High-resolution computed tomography in patients with bronchial asthma: correlation with clinical features, pulmonary functions and bronchial hyperresponsiveness Journal of Investigational Allergology and Clinical Immunology 7(3): 186-192
Scadding, G.K.; Lund, V.J.; Holmstrom, M.; Darby, Y.C. 1991: Clinical and physiological effects of fluticasone propionate aqueous nasal spray in the treatment of perennial rhinitis RHINOLOGY. Suppl 11: 37-43
Cancelliere, N.; Bobolea, I.; López-Carrasco, V.; Barranco, P.; López-Serrano, C.; Quirce, S. 2013: Comparative study of bronchial hyperresponsiveness to methacholine and mannitol in the initial diagnosis of asthma Journal of Investigational Allergology and Clinical Immunology 23(5): 361-362
Fukuda, T.; Akutsu, I.; Nakajima, K.; Fukushima, Y.; Numao, T.; Ando, N.; Motojima, S.; Makino, S. 1990: The role of eosinophils, neutrophils and lymphocytes for the development of bronchial hyperresponsiveness in a guinea pig model of asthma Nihon Kyobu Shikkan Gakkai Zasshi 28(10): 1288-1293
Kroczyńska-Bednarek, J.; Gondorowicz, K.; Kalinowska-Graczyk, M.; Grzelewska-Rzymowska, I.; Rozniecki, J. 1996: Bronchial hyperresponsiveness in patients with seasonal allergic rhinitis and the influence of loratadine and beclomethasone on this hyperresponsiveness Pneumonologia i Alergologia Polska 64(3-4): 182-188
Kaneko, F.; Akiyama, K. 1996: Bronchial asthma as an inflammation and the use of inhaled steroid Nihon Rinsho. Japanese Journal of Clinical Medicine 54(11): 2962-2968